期刊文献+

甲状腺组织中免疫调节T淋巴细胞的比例 被引量:4

Proportion of Immune Regulatory T Cells in Thyroid
下载PDF
导出
摘要 目的观察正常甲状腺及Graves病(GD)患者甲状腺组织中免疫调节T淋巴细胞的比例。方法采用流式细胞术分别检测20例正常甲状腺及9例GD患者甲状腺中Treg细胞、Th1细胞、Th2细胞比例,并与外周血进行对比。结果外周血、正常甲状腺、GD甲状腺中Treg细胞比例分别为1.79±0.43%、17.07±10.16%、20.87±13.26%,Th1细胞比例分别为14.45±2.46%、17.28±3.02%、8.62±1.88%,Th2细胞比例分别为1.44±0.31%、1.78±0.55%、6.87±3.27%。与外周血相比,正常甲状腺及GD甲状腺中Treg细胞比例明显增高(P<0.01),与正常甲状腺相比,GD甲状腺中Th1细胞比例明显降低(P<0.05),Th2细胞比例明显升高(P<0.01)。结论甲状腺组织局部存在着数量明显增多的Treg细胞,GD患者的甲状腺中存在Th1/Th2细胞失衡。 Objective To evaluate the proportion of immune regulatory T cells in normal thyroid and GD thyroid. Methods The proportion of regulatory T ceils (Tregs), T helper t (ThI) ceils, Th2 ceUs in 20 normal thyroids and 9 thyroids of GD patients were analyzed by flow cytometry and then compared to the proportion in peripheral blood. Results In peripheral blood, normal thyroid and GD thyroid, the proportion of Tregs were 1.79 ± 0.43%, 17.07 ± 10.16%, 20.87 ± 13.26% ; the proportion of Thl cells were 14.45 ± 2.46%, 17.28 ± 3.02% , 8.62 ± 1.88% , and the proportion of Th2 cells were 1.44 ±0.31% , 1.78 ±0.55% , 6.87 ± 3.27%. Compared to peripheral blood, the proportion of Tregs was significantly increased in normal thyroid and GD thyroid (P 〈 0.01 ). Compared to normal thyroid, the proportion of Thl cells significantly decreased (P 〈0.05) and the proportion of Thl cells significantly increased in GD thyroid (P 〈0.01 ). Conclusion Tregs are abundant in thyroid tissue and there is an imbalance of Thl/Th2 cells in GD thyroid tissue.
出处 《标记免疫分析与临床》 CAS 2015年第5期445-449,共5页 Labeled Immunoassays and Clinical Medicine
基金 南京市医学科技发展项目(ZKX12023)
关键词 甲状腺 GRAVES病 调节性T细胞 辅助性T细胞 Thyroid Graves' disease Regulatory T cells (Treg) T helper cells
  • 相关文献

参考文献14

  • 1Bluestone J A, Auchincloss H, Nepom G T, et al. The Immune Tolerance Network at 10 years: tolerance research at the bedside. Nat Rev Immunol,2010, 10( 11 ) : 797-803.
  • 2Hu Y, Tian W, Zhang L L, et al. Function of regulatory T-cells improved by dexamethasone in Graves' disease. Eur J Endocrinol, 2012, 166(4) : 641-646.
  • 3Mao C, Wang S, Xiao Y, et al. Impairment of Regulatory Capacity of CD4 + CD25 + Regulatory T Ceils Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease. J Immunol, 2011, 186(8) : 4734-4743.
  • 4Glick A B, Wodzinski A, Fu P, et al. Impairment of Regulatory T- Cell Function in Autoimmune Thyroid Disease. Thyroid. 2013, 23 (7) : 871-878.
  • 5Saitoh O, Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4 + CD25 + regulatory T cells in a mouse model. Endocrinology, 2006, 147 (5) : 2417-2422.
  • 6Zhou J, Bi M, Fan C, et al. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism. Clin Exp Med, 2012, 12(1) : 39-46.
  • 7Marazuela M, Garcia- L6pez M A, Figueroa- Vega N, et al. Regulatory T Cells in Human Autoimmune Thyroid Disease. J Clinical Endocrinol Metab,2006, 91 (9) : 3639-3646.
  • 8何珂,胡蕴,毛晓明.Graves病患者外周血免疫调节细胞及其亚群比例异常[J].细胞与分子免疫学杂志,2014,30(11):1190-1193. 被引量:14
  • 9Josefowicz S Z, Lu L, Rudensky A Y. Regulatory T Cells: Mechanisms of Differentiation and Function. Annu Rev Immunol, 2012, 30(1): 531-564.
  • 10Inukai Y, Momobayashi A, Sugawara N, et al. Changes in expression of T- helper ( Th ) 1- and Th2- associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation- regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease. Eur J Endocrinol, 2007, 156(6) : 623-630.

二级参考文献21

  • 1Bluestone JA, Auchincloss H, Nepom GT, et al. The Immune Tolerance Network at 10 years: tolerance research at the bedside [J]. Nat Rev Immunol, 2010, 10 (11) : 797 - 803.
  • 2Li H, Wang T. The autoimmunity in Graves's disease[J]. Front Biosci (Landmark Ed), 2013,18: 782 -787.
  • 3Morshed SA, LWf R, Davies 'IF. Delineating the autoimrnme IreChanisms in Graves' disease[J]. Immunol Res, 2012, 54(112/3): 191-203.
  • 4Sakaguchi S. Naturally arising F0xp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self [J]. Nat Immunol, 2005, 6 (4) : 343 - 352.
  • 5Hu Y, Tian W, Zhang LL, et al. Function of regulatory T cells improved by dexamethasone in Graves' disease [J] . Eur J Endocrinol, 2012,166(4): 641 -646.
  • 6Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique COl d hi CD5 + phenotype controls T cell-dependent inflammatory responses [J]. Immunity, 2008, 28 (5) : 639 - 650.
  • 7Zanoni I, Granucci F. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance [J]. Autoimmunity, 2011, 44(1) : 23 -32.
  • 8Kalantari T, Kamali-Sarvestani E, Ciric B, et al. Generation of immunogenic and tolerogenic clinical-grade dendritic cells [J]. Immunol Res, 2011, 51 (2/3): 153 -160.
  • 9Zhou J, Bi M, Fan C, et al. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism [J]. Clin Exp Med, 2012, 12(1): 39 -46.
  • 10Saitoh 0, Nagayama Y. Regulation of graves' hyperthyroidism with naturally occurring CD4 + CD25 + regulatory T cells in a mouse model [J]. Endocrinology, 2006,147(5): 2417 -2422.

共引文献13

同被引文献23

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部